Replimune Group, Inc.
REPL
23 insider filings · Latest: Jun 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 4 12:30 AM | Christopher SarchiChief Commercial Officer | Sale | 12,000 | $9.24 | $110.9K | 180,962(D) | View → |
| May 18, 2026 | May 20 8:18 PM | Konstantinos XynosChief Medical Officer | Sale | 14,023 | $5.08 | $71.2K | 235,662(D) | View → |
| May 18, 2026 | May 20 8:17 PM | Andrew SchwendenmanChief Accounting Officer | Sale | 7,894 | $5.08 | $40.1K | 107,057(D) | View → |
| May 18, 2026 | May 20 8:16 PM | Christopher SarchiChief Commercial Officer | Sale | 8,626 | $5.08 | $43.8K | 192,962(D) | View → |
| May 18, 2026 | May 20 8:16 PM | Philip Astley-SparkeDirector | Sale | 17,657 | $5.08 | $89.7K | 1,412,414(D) | View → |
| May 18, 2026 | May 20 8:15 PM | Sushil PatelDirector, Chief Executive Officer | Sale | 37,324 | $5.08 | $189.6K | 747,492(D) | View → |
| May 18, 2026 | May 20 8:15 PM | Emily Luisa HillChief Financial Officer | Sale | 7,812 | $5.08 | $39.7K | 236,556(D) | View → |
| Apr 2, 2026 | Apr 6 8:30 PM | Christopher SarchiChief Commercial Officer | Sale | 6,500 | $8.01 | $52.1K | 151,588(D) | View → |
| Apr 2, 2026 | Apr 2 8:15 PM | Christopher Sarchi | Proposed Sale | 18,500 | $7.70 | $142.4K | — | View → |
| Dec 9, 2025 | Dec 9 9:00 PM | Kapil Dhingra | Proposed Sale | 3,164 | $10.38 | $32.8K | — | View → |
| Dec 2, 2025 | Dec 2 9:11 PM | Sushil Patel | Proposed Sale | 10,000 | $11.13 | $111.3K | — | View → |
| Dec 16, 2024 | Dec 16 9:48 PM | Sushil Patel | Proposed Sale | 15,000 | $12.57 | $188.6K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Apr 8 1:15 AM | BAKER BROS. ADVISORS LPDirector, 10% Owner | Grant/Award | 89,000 | $7.61 | 44,500(I) | View → |
| Apr 1, 2026 | Apr 8 1:11 AM | Christopher SarchiChief Commercial Officer | Grant/Award | 75,000 | $7.61 | 75,000(D) | View → |
| Apr 1, 2026 | Apr 8 1:10 AM | Philip Astley-SparkeDirector | Grant/Award | 75,000 | $7.61 | 75,000(D) | View → |
| Apr 1, 2026 | Apr 8 1:10 AM | Christy J. OligerDirector | Grant/Award | 44,500 | $7.61 | 44,500(D) | View → |
| Apr 1, 2026 | Apr 8 1:10 AM | Konstantinos XynosChief Medical Officer | Grant/Award | 75,000 | $7.61 | 75,000(D) | View → |
| Apr 1, 2026 | Apr 8 1:09 AM | Madhavan BalachandranDirector | Grant/Award | 44,500 | $7.61 | 44,500(D) | View → |
| Apr 1, 2026 | Apr 8 1:09 AM | Andrew SchwendenmanChief Accounting Officer | Grant/Award | 55,000 | $7.61 | 55,000(D) | View → |
| Apr 1, 2026 | Apr 8 1:09 AM | Sushil PatelDirector, Chief Executive Officer | Grant/Award | 376,860 | $7.61 | 376,860(D) | View → |
| Apr 1, 2026 | Apr 8 1:09 AM | Kapil DhingraDirector | Grant/Award | 44,500 | $7.61 | 44,500(D) | View → |
| Apr 1, 2026 | Apr 8 1:08 AM | Paolo PucciDirector | Grant/Award | 44,500 | $7.61 | 44,500(D) | View → |
| Apr 1, 2026 | Apr 8 1:08 AM | Joseph P SlatteryDirector | Grant/Award | 44,500 | $7.61 | 44,500(D) | View → |
| Apr 1, 2026 | Apr 8 1:08 AM | Veleka Peeples-DyerDirector | Grant/Award | 44,500 | $7.61 | 44,500(D) | View → |
| Apr 1, 2026 | Apr 8 1:08 AM | Emily Luisa HillChief Financial Officer | Grant/Award | 75,000 | $7.61 | 75,000(D) | View → |
| Apr 1, 2026 | Apr 8 1:07 AM | Dieter WeinandDirector | Grant/Award | 44,500 | $7.61 | 44,500(D) | View → |